Skip to main content
logo
Cambium Bio Limited (ASX:CMB)
Australia flag Australia · Delayed Price · Currency is AUD
0.4100
0.00 (0.00%)
Aug 5, 2026, 11:49 AM AEST

Cambium Bio Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Revenue
0.670.770.181.01
Revenue Growth
-13.69%337.80%-82.55%-
Gross Profit
0.460.570.131.01
Operating Income
-3.94-4.19-1.71-1.2
Net Income
-3.57-3.84-2.26-1.69
Earnings Per Share
-0.16-0.21-0.54-0.55
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Cash & Investments
0.770.172.860.3
Total Debt
0.410.480.470.35
Net Cash (Debt)
0.36-0.322.4-0.04
Net Cash Growth
----
Net Cash Per Share
0.02-0.020.57-0.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Operating Cash Flow
-3.89-5.24-0.16-0.66
Capital Expenditures
-0-0.01--
Free Cash Flow
-3.89-5.25-0.16-0.66
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Jun '25 Jun '24 Jun '23
Gross Margin
68.38%74.09%72.59%100.00%
Operating Margin
-589.82%-540.83%-964.22%-118.76%
Pretax Margin
-534.44%-496.11%-1274.48%-166.33%
Profit Margin
-534.44%-496.11%-1274.48%-166.33%
FCF Margin
-582.07%-677.17%-88.06%-65.12%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Jun '25 Jun '24 Jun '23
PS Ratio
16.764.9633.70-